Does Your Business Have the Tools to Compete in the World's Largest Diagnostics Markets?

Does Your Business Have the Tools toDoes Your Business Have the Tools to Compete in the World's Largest Diagnostics Markets? PR Newswire MOUNTAIN VIEW, California, Oct. 30, 2013 -- Frost & Sullivan participates in IVD Business Strategy Conference evaluating useful approaches to excel in a cost-constrained industry The inclusive and increasingly competitive in vitro diagnostics (IVD) landscape is evolving in unison with healthcare reform. Therefore, it is vital for all market participants to understand the transformation and manage amidst the changes. Those even remotely invested in the market require crucial insight on business strategy and regulatory and technological advancements essential for success, in addition to current and future growth trends and market opportunities that will keep them a key player. "Global IVD companies have been forced to adjust to a lower healthcare spending baseline for what is currently the world's largest IVD market, the United States," said Frost & Sullivan Life Sciences Senior Industry Analyst Winny Tan. "We used to describe the diagnostics market as highly cost- sensitive; now it is the entire healthcare industry that is cost-constrained. Competing in this business environment means growth strategies need to deliver the greatest value with low upfront investments.